Sell Ajanta Pharma, target Rs 1245: Dr CK Narayan

Dr CK Narayan of Chart Advise has a sell call on Ajanta Pharma Ltd. with a target price of Rs 1245. The current market price of Ajanta Pharma Ltd. is Rs 1266.5 Time period given by analyst is Intra Day when Ajanta Pharma Ltd. price can reach defined target.
Dr CK Narayan recommended to keep stop loss at Rs 1280.

Ajanta Pharma Ltd., incorporated in 1979, is a mid-cap company with a market cap of Rs 11147.04 crore.


Ajanta Pharma Ltd. key products/revenue segments include pharmaceutical products which contributed Rs 1753.68 crore to sales value (96.21 % of total sales), Export incentives which contributed Rs 66.83 crore to sales value (3.66 % of total sales) and other operating revenue which contributed Rs 2.20 Crore to sales value (0.12 % of total sales) for the year ending 31-Mar-2017.

For the quarter ended 31-03-2018, the company has reported a consolidated sales of Rs 530.31 crore, down -9.67 % from last quarter sales of Rs 587.05 crore and up 16.27 % from last year same quarter sales of Rs 456.12 crore.

The company has reported net profit after tax of Rs 94.49 crore in the latest quarter.

The company’s top management includes Dr.Anil Kumar, Dr.Anjana Grewal, Mr.Chandrakant M Khetan, Mr.K H Viswanathan, Mr.Madhusudan B Agrawal, Mr.Mannalal B Agrawal, Mr.Prabhakar Dalal, Mr.Purushottam B Agrawal, Mr.Rajesh M Agrawal, Mr.Yogesh M Agrawal. Company has Kapoor & Parekh Associates as its auditoRs As on 31-03-2018, the company has a total of 88,014,500 shares outstanding.